New drug tested for debilitating shingles pain
NCT ID NCT01106716
Summary
This study tested whether a single dose of an experimental drug called KAI-1678 could safely reduce severe nerve pain in people with postherpetic neuralgia, a painful condition that can follow shingles. It was a small, Phase 2 trial that compared the drug against a placebo and another pain medication. The main goal was to see if the drug could lower pain intensity six hours after it was given.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTHERPETIC NEURALGIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sydney, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.